ICD-10 Coding for Pheochromocytoma(C74.1, D35.00)
Complete ICD-10-CM coding and documentation guide for Pheochromocytoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Pheochromocytoma
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C74.1 | Malignant neoplasm of adrenal medulla | Use when there is confirmed malignancy of the adrenal medulla. |
|
| D35.00 | Benign neoplasm of adrenal gland, unspecified | Use when the tumor is benign and confined to the adrenal gland. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for pheochromocytoma
Essential facts and insights about Pheochromocytoma
Primary ICD-10-CM Codes for pheochromocytoma
Decision Criteria
clinical Criteria
- Presence of metastasis or invasive growth
Applicable To
- Malignant pheochromocytoma
Excludes
- Benign pheochromocytoma (D35.00)
Clinical Validation Requirements
- Pathology confirmation of malignancy
- Imaging showing metastasis
Code-Specific Risks
- Incorrectly coding benign tumors as malignant
Coding Notes
- Ensure malignancy is confirmed via pathology before coding.
D35.00 - Benign neoplasm of adrenal gland, unspecified
Use when the tumor is benign and confined to the adrenal gland.
Applicable To
- Benign pheochromocytoma
Excludes
- Malignant pheochromocytoma (C74.1)
Clinical Validation Requirements
- Imaging and biochemical confirmation without invasion
Coding Notes
Biochemical tests should confirm the benign nature of the tumor.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Hypertension secondary to endocrine disorders
I15.2Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Pheochromocytoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C74.1.
Impact
Clinical: Incomplete clinical picture of the patient's condition., Regulatory: Non-compliance with coding guidelines., Financial: Potential loss of reimbursement for related treatments.
Mitigation Strategy
Review patient history for hypertension, Ensure linkage to pheochromocytoma in documentation
Impact
Reimbursement: Incorrect coding can lead to overpayment or claim denial., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation Strategy
Ensure pathology reports confirm malignancy before coding as C74.1.
Impact
Risk of misclassification affecting reimbursement and compliance.
Mitigation Strategy
Require pathology confirmation before coding malignancy.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Pheochromocytoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Pheochromocytoma
Use these documentation templates to ensure complete and accurate documentation for Pheochromocytoma. These templates include all required elements for proper coding and billing.
Pheochromocytoma diagnosis and management
Specialty: EndocrinologyRequired Elements
- Biochemical test results
- Imaging findings
- Genetic testing results
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Pheochromocytoma? Ask your questions below.